Mainz Biomed N.V.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company’s flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
/ 
Frequently asked questions
To buy Mainz Biomed N.V. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Mainz Biomed N.V. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Mainz Biomed N.V. is MYNZ:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Mainz Biomed N.V. has its primary listing on NASDAQ (Small cap). You can trade Mainz Biomed N.V. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Mainz Biomed N.V. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Mainz Biomed N.V. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Mainz Biomed N.V..